Clinical effectiveness of a manual based coping strategy programme (START, STrAtegies for RelaTives) in promoting the mental health of carers of family members with dementia: pragmatic randomised controlled trial by Livingston, Gill et al.
  
Gill Livingston, Julie Barber, Penny Rapaport, Martin 
Knapp, Mark Griffin, Derek King, Debbie Livingston, Cath 
Mummery, Zuzana Walker, Juanita Hoe, Elizabeth L. 
Sampson and Claudia Cooper  
Clinical effectiveness of a manual based 
coping strategy programme (START, 
STrAtegies for RelaTives) in promoting the 
mental health of carers of family members 
with dementia: pragmatic randomised 
controlled trial 
 
Article (Published version) 
(Refereed) 
 
 
 
 
Original citation: 
Livingston, Gill, Barber, Julie, Rapaport, Penny, Knapp, Martin, Griffin, Mark, King, Derek, 
Livingston, Debbie, Mummery, Cath, Walker, Zuzana, Hoe, Juanita, Sampson, Elizabeth L. and 
Cooper, Claudia (2013) Clinical effectiveness of a manual based coping strategy programme 
(START, STrAtegies for RelaTives) in promoting the mental health of carers of family members 
with dementia: pragmatic randomised controlled trial. BMJ, 347 (f6276). pp. 1-14. ISSN 0959-
8138 DOI: 10.1136/bmj.f6276 
 
© 2013 BMJ Publishing Group Ltd. 
 
This version available at: http://eprints.lse.ac.uk/54231/ 
Available in LSE Research Online: Nov 2013 
 
LSE has developed LSE Research Online so that users may access research output of the 
School. Copyright © and Moral Rights for the papers on this site are retained by the individual 
authors and/or other copyright owners. Users may download and/or print one copy of any 
article(s) in LSE Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities 
or any commercial gain. You may freely distribute the URL (http://eprints.lse.ac.uk) of the LSE 
Research Online website.  
Clinical effectiveness of a manual based coping
strategy programme (START, STrAtegies for RelaTives)
in promoting the mental health of carers of family
members with dementia: pragmatic randomised
controlled trial
OPEN ACCESS
Gill Livingston professor of older people’s mental health1, Julie Barber lecturer in medical statistics2,
Penny Rapaport principal clinical psychologist 3, Martin Knapp professor of social policy 4, Mark
Griffin lecturer in medical statistics 2, Derek King research fellow 5, Debbie Livingston trial manager 1,
Cath Mummery consultant neurologist, honorary senior lecturer 6, ZuzanaWalker reader in psychiatry
of the elderly 1, Juanita Hoe senior clinical research associate 1, Elizabeth L Sampson clinical senior
lecturer 1, Claudia Cooper clinical senior lecturer 1
1Mental Health Science, University College London, LondonW1W 7EJ, UK ; 2Statistical Science and PRIMENT clinical trials unit, University College
London, Gower Street, London, UK; 3Camden and Islington NHS Foundation Trust, London, UK; 4Personal Social Services Research Unit, London
School of Economics and Political Science, London, UK; 5Institute of Psychiatry, King’s College London, UK; 6Dementia Research Unit, University
College London
Abstract
Objective To assess whether a manual based coping strategy compared
with treatment as usual reduces depression and anxiety symptoms in
carers of family members with dementia.
Design Randomised, parallel group, superiority trial.
Setting Three mental health community services and one neurological
outpatient dementia service in London and Essex, UK.
Participants 260 carers of family members with dementia.
Intervention A manual based coping intervention comprising eight
sessions and delivered by supervised psychology graduates to carers
of family members with dementia. The programme consisted of
psychoeducation about dementia, carers’ stress, and where to get
emotional support; understanding behaviours of the family member being
cared for, and behavioural management techniques; changing unhelpful
thoughts; promoting acceptance; assertive communication; relaxation;
planning for the future; increasing pleasant activities; and maintaining
skills learnt. Carers practised these techniques at home, using the
manual and relaxation CDs.
Main outcome measures Affective symptoms (hospital anxiety and
depression total score) at four and eight months. Secondary outcomes
were depression and anxiety caseness on the hospital anxiety and
depression scale; quality of life of both the carer (health status
questionnaire, mental health) and the recipient of care (quality of
life-Alzheimer’s disease); and potentially abusive behaviour by the carer
towards the recipient of care (modified conflict tactics scale).
Results 260 carers were recruited; 173 were randomised to the
intervention and 87 to treatment as usual. Mean total scores on the
hospital anxiety and depression scale were lower in the intervention
group than in the treatment as usual group over the eight month
evaluation period: adjusted difference in means −1.80 points (95%
confidence interval −3.29 to −0.31; P=0.02) and absolute difference in
means −2.0 points. Carers in the intervention group were less likely to
have case level depression (odds ratio 0.24, 95% confidence interval
0.07 to 0.76) and there was a non-significant trend towards reduced
case level anxiety (0.30, 0.08 to 1.05). Carers’ quality of life was higher
in the intervention group (difference in means 4.09, 95% confidence
interval 0.34 to 7.83) but not for the recipient of care (difference in means
0.59, −0.72 to 1.89). Carers in the intervention group reported less
Correspondence to: G Livingston g.livingston@ucl.ac.uk
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Research protocol
The START manual: STrAtegies for RelaTives
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abusive behaviour towards the recipient of care compared with those in
the treatment as usual group (odds ratio 0.47, 95% confidence interval
0.18 to 1.23), although this was not significant.
Conclusions Amanual based coping strategy was effective in reducing
affective symptoms and case level depression in carers of family
members with dementia. The carers’ quality of life also improved.
Trial registration Current Controlled Trials ISCTRN70017938.
Introduction
The number of people living with dementia is rising rapidly
owing to increased longevity. Dementia not only affects the
person with the condition but also family members and society,
through increasing dependence and challenging behaviour.1 In
the United Kingdom, dementia care is estimated to cost £23bn
per year, and this is projected to treble in the next 30 years as
the number of older people increases.2 Families and individuals
bear the biggest burden; two thirds of people with dementia live
at home and receive most of their care from family members,
who therefore save the economy a considerable amount of
money.2About 40% of carers of family members with dementia
have clinically significant depression or anxiety, and others
have significant psychological symptoms.3 4 These symptoms
are more common when the family carer is older, a woman,
living with the recipient of care, reports a greater carer burden,
and the care recipient has more neuropsychiatric symptoms,
although they seem unrelated to the severity of the dementia.3 4
The psychological morbidity of carers predicts a breakdown in
care and therefore the need for placement in a care home5as well
as elder abuse.6 Thus improving the psychological health of the
carers may not only improve their quality of life but also that
of the recipient of their care. In the long term the need for
placement in a care home may be delayed and thus bring
economic benefits.
Although UK policy recognises that psychological therapy for
carers of family members with dementia should be a key
component of high quality dementia care, in practice resources
are not available, and this is partly because so far effective
therapies have been delivered only by highly trained clinical
psychologists and evidence on cost effectiveness is lacking.7
The national agenda in the United Kingdom is to have a stepped
care approach to improve access to psychological therapies,
where less intensive therapy is delivered8 by graduates
supervised by clinical psychologists. A befriending programme
delivered by former carers was ineffective in reducing the carers’
anxiety or depression.9 The Coping with Caregiving programme
was developed in the United States.10 11 This manual based group
intervention comprising 12 sessions delivered by clinical
psychologists has been shown to reduce depression.12 13
Therapies individualised to carers seem to be most effective in
delaying admission of the recipients of care to a care facility
and are more effective than group interventions in reducing
morbidity in carers.12 14 Interventions that require active
participation of caregivers have the greatest effect.15
We carried out a randomised controlled trial in the United
Kingdom to test a manual based therapy for carers of family
members with dementia and to test the effectiveness of using
psychology graduates without clinical qualifications to deliver
therapy to this group.
Methods
The supplementary file provides the full protocol of this
pragmatic multicentre randomised controlled trial. Our
intervention, based on the US Coping with Caregiving
programme, was individual andmanualised and required active
participation. Our primary objective was to determine the
clinical effectiveness (measured by the hospital anxiety and
depression scale) and cost effectiveness (reported in an
accompanying paper16) of eight sessions of a manual based
coping strategy, delivered over 8-14 weeks by supervised
psychology graduates to carers of family members with
dementia, compared with usual service provision, over eight
months.
The secondary outcomes were depression and anxiety caseness
on the hospital anxiety and depression scale; quality of life of
both the carer and the recipient of the care; and abusive
behaviour by the carer. We plan on analysing time to entry to
24 hour care of the family member with dementia at longer term
follow-up (at two and seven years).
Recruitment and follow-up
We recruited carers to the trial from 4November 2009 to 8 June
2011. The first four month follow-up took place on 4 March
2010, with the final eight month follow-up on 7 February 2012.
Setting
We recruited through disparate settings: twomental health trusts’
memory services (Camden and Islington Foundation Trust,
urban setting; North Essex Partnership Foundation Trust,
suburban and rural); the North East London Foundation Trust
Admiral nurse, suburban (specialist nurses for carers of family
members with dementia); and the Dementia Research
Centre-National Hospital for Neurology and Neurosurgery, a
tertiary service with a high rate of referrals for young people
with early onset dementia.
Participants
We included carers of family members referred in the previous
year who provided emotional or practical support at least weekly
and identified themselves as the primary carer of a family
member with dementia not living in 24 hour care. We excluded
carers who were unable to give informed consent to the trial,
were currently taking part in a randomised controlled trial in
their capacity as a carer, or who lived more than 1.5 hours
travelling time from the researchers’ base.We administered the
mini-mental state examination17 to carers aged 60 or over only
at baseline. If they scored less than 24 the research assistant
discussed the participant with GL or CC to see whether this was
related to cognition, mood, or education. If carers were judged
to have a dementia they were not included in the study and we
informed the referring clinician.
Procedure
Prospective participants were initially approached by a clinician
and given or sent an information sheet. Those interested in
participating were referred to the research team. The referral
gave the name, sex, and relationship to the family member of
the prospective participant as well as the patient’s sex. The
researchers telephoned the carer 24 hours or more after they
received the information sheet. The researchers answered any
questions and then arranged to meet those who agreed to take
part to obtain their informed consent and complete baseline
assessment before randomisation.
Allocation to trial groups
To conceal allocation we used an online computer generated
randomisation system to allocate participants to the intervention
or to treatment as usual. This system was set up and maintained
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by an independent clinical trials unit and accessed by the START
trial manager. Randomisation was stratified by trust using
random permuted blocks. To allow for potential clustering
effects in the intervention arm we used an allocation ratio of
2:1 (intervention: treatment as usual).18Amember of the therapy
team then phoned the participants and informed them of their
allocation, either to treatment as usual when they would be
contacted for a four month follow-up or to the intervention when
an appointment was made for the therapy to start. Allocation
within the individual teams was according to workload.
Assessments
Carers were interviewed at baseline and at four and eight months
after randomisation, usually in their own home, unless they
preferred to come to the research team base in University
College London.We have continued to follow up carers, asking
them to remain in the study for two years even if the recipient
of their care had been placed in a care home or died. Results of
this longer term follow-up will be reported separately.
Information collected at baseline consisted of sociodemographic
details about the carer and recipient of the care; and clinical and
resource use items (as detailed in the accompanying paper). At
both the four and eight month follow-up we repeated the
collection of clinical and resource use information.
Sociodemographic details obtained at baseline included age,
sex, ethnicity, relationship to the recipient of care (for example,
spouse, child), level of education, last occupation, and living
situation.
Measures regarding the carer’s health and wellbeing collected
at all three study time points were:
• The hospital anxiety and depression scale,19 a self
completed scale, which has been validated for all age
groups and settings, in people who are physically well or
unwell, and in Asian and African ethnic groups.20 The scale
determines caseness of depression and anxiety with scores
ranging from 0 to 21 and as a total score ranging from 0
to 42 (higher scores indicating more symptoms). We chose
the total score as our primary outcome because it has a
better sensitivity and positive predictive value than either
of the individual scales in identifying depression when
compared with the international classification of diseases
criteria.21 The anxiety and depression score was also
dichotomised as “case” and “non-case,” with a cut-off point
of 8/9.20
• The Zarit burden interview, a 22 item self report
questionnaire, is the most consistently used measure of
burden in carers22; scores range from 0 to 88, with higher
scores indicating more burden.
• The modified conflict tactics scale is a self completed
measure of potentially abusive behaviour by carers towards
the recipient of their care.23 Ten behaviours are scored as
to whether, during the previous three months, these have
occurred never (0), almost never (1), sometimes (2), most
of the time (3), or all of the time (4), and these items can
be added to make a score. These behaviours range from
shouting to threatening to shaking or slapping. A score of
2 or more on any one of the items is classified as an abusive
behaviour. If participants scored this on any item, we
discussed the score with a supervising clinician and if it
was judged that the recipient of care was at risk, permission
was asked to inform the clinical team so that the carer and
recipient of care could have appropriate help.
• Health status questionnaire,24 25 mental health domain,
measures health related quality of life throughout the age
ranges and is sensitive to change. It is summarised as a
continuous score, ranging from 0 to 100, with higher scores
indicating better outcome.
• The brief COPE, a self completed measure of coping
strategies by the carer, validated in carers of family
members with dementia, with subscales that measure
problem focused, emotion focused, and dysfunctional
coping.26 27
At all time points, we also asked carers for information about
the recipient of their care:
• The neuropsychiatric inventory28 is a validated instrument
with 12 symptom domains that are scored for their severity
and frequency and summarised as a single continuous score
(higher scores indicating worse symptoms). We included
this tool as neuropsychiatric symptoms have been shown
to be associated with psychological morbidity of carers.
• The clinical dementia rating, which we used as an
informant instrument, grades the level of impairment of
someone with dementia (categories: healthy, very mild,
mild, moderate, severe).29
• Quality of life-Alzheimer’s disease30 was rated by the
carers, to assess the family member’s overall quality of
life. The total score ranges from 13 to 52, with higher
scores indicating better outcome.
Blinding
We blinded outcome assessors to randomisation status, but it
was not possible to blind the study participants. The researchers
worked in two teams, each assessing outcomes for
approximately half the participants and providing therapy to
those allocated to treatment in the half of participants they were
not assessing. Assessors asked participants at the beginning of
each interview not to disclose their allocation group.
Therapy intervention
With the first author’s permission, we developed an individual
therapy programme (START, STrAtegies for RelaTives) based
on the Coping with Caregiving programme from the United
States. We adapted it for UK use for individual carers of family
members with dementia over eight sessions (box). The therapy
took place where the carers preferred, usually in their homes,
without the family member with dementia in the room. The
therapy was carried out with an interpreter if the carer did not
speak English fluently.
Training and delivery
We employed and trained psychology graduates with no clinical
training to deliver the intervention. The training programme
had a strong practical focus on how to deliver the therapy,
potential clinical dilemmas, working with interpreters, empathic
listening skills, effective use of supervision, and when to ask
for help. We trained the therapists to adhere to the manual and
required them to demonstrate, by role play, competence in
delivering each session of the intervention. Our clinical
psychologist (PR) met with each team of therapists for 1.5 hours
of group clinical supervision every fortnight. She also had one
hour of dedicated time per week for individual consultation as
needed by the therapists. The therapists recorded one therapy
session per participant, selected at random, and a researcher not
involved in the therapy used a standard checklist to rate the
session for fidelity to the manual. Overall fidelity scores ranged
from 1 to 5, with 5 being high. If fidelity scores were not high
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Structure of STrAtegies for RelaTives programme
Introduction
Learning about dementia, stress in carers, and understanding behaviours of the recipient of care
Discussion
Discussion of behaviours or situations that carers found difficult, incorporating behavioural management techniques, skills to take better
care of themselves (including changing unhelpful thoughts), relaxation, increasing and assertive communication, promoting acceptance,
sources of emotional support, and positive reframing
Future needs of the family member with dementia
Information about care and legal planning, specifically adapted to the United Kingdom. We gave the carers information leaflets about
making common decisions as appropriate at an individual level31
Planning pleasant activities
This used the idea that it is possible, beneficial, and pleasurable to incorporate small pleasant activities into a caring day.
Maintaining skills learnt over time
In the last session the carer identified which techniques they found helpful and made a plan about what to continue for the future. Carers
were given homework tasks to complete between sessions, including relaxation, identifying triggers and reactions to challenging
behaviours, and identifying and challenging negative thoughts. The therapist and the carer both had a manual and the carer filled in
and kept their own manual. Relaxation exercises used in sessions were recorded on a CD and given to the carers. We defined adherence
to therapy on clinical grounds as participating in five or more sessions
the supervising clinical psychologist discussed this in
supervision.
Treatment as usual
In the treatment as usual group, services were based around the
family member with dementia. Standard treatment concerns
medical, psychological, and social issues. Thus the treatment
consisted of assessment, diagnosis, and information; drug
treatment; cognitive stimulation therapy; practical support;
treatment of neuropsychiatric and cognitive symptoms; and
carer support. In each setting, treatments aimed to be in line
with the clinical guidelines for good dementia care of the
National Institute for Health and Care Excellence.32
Power calculation
This study was originally powered for a primary outcome of
anxiety score on the hospital anxiety and depression scale based
on data from a cross sectional pilot study of carers of family
members with dementia. Mean anxiety scores for this group
were 7.2 (SD 4) points. We considered a decrease of 2 points
in mean score and 0.5 change in standard deviation to be
clinically significant (expert consensus). To detect such a
difference with 90% power at a 5% significance level, we
required 75 participants in each group. To account for therapist
clustering, we used a design effect of 1.87 for the intervention
group, assuming an average of 30 carers per therapist and an
intracluster correlation of 0.03.33 Based on these calculations
and inflating for 20% attrition, we planned to recruit 90
participants in the treatment as usual group (no clustering) and
168 participants in the intervention group (clustering).
After recruitment, the research team (with approval from the
funding body while the database was still locked) agreed that
the primary outcome should be changed to the total score on
the hospital anxiety and depression scale as this has been shown
to have better sensitivity and positive predictive value than
either of the individual anxiety and depression scores in
identifying depression. We calculated that the sample size then
available (87 treatment as usual, 173 intervention group) would
be sufficient to detect a mean difference in total score on the
hospital anxiety and depression scale of at least 2.4 points (with
80% power, 5% significance), which was considered to be
clinically important. This calculation assumed a standard
deviation for the total score of 7.4 (as seen in pilot data), allowed
for analysis of covariance (with assumed correlation 0.5), and
repeated follow-up measurements at four and eight months
(assumed correlation 0.7).We factored in drop-out rates at 10%
(based on that observed), and we applied a revised design effect
of 1.4 for the intervention arm (using an intracluster correlation
of 0.0334 and the observed average cluster size of 15 carers for
each therapist).
Statistical analysis
In the primary analysis we used regression methods to estimate
group differences in total score on the hospital anxiety and
depression scale over the eight month follow-up. We used
random effects models to account for the therapist clustering in
the intervention arm and repeated measurements at four and
eight months. We adjusted for baseline total score and centre
(on which randomisation was stratified) and also on factors
believed to affect affective symptoms (carer’s age, sex, carer
burden, and neuropsychiatric symptoms of the recipient of the
care). We carried out all analyses by intention to treat but
excluded carers with data missing at both the four and the eight
month follow-up.
We used sensitivity analyses to reanalyse the primary outcome
and to assess robustness of our conclusions. Analyses considered
adjustment for imbalances in baseline characteristics between
the randomised groups and the differential effects of treatment
over time (treatment by time interaction). Using logistic
regression we also investigated the extent to which missing
outcomes varied by baseline characteristics; we then repeated
the main analyses adjusting for those factors associated with
missingness.
We applied similar approaches for analysis of the secondary
outcomes. For binary outcomes we used random effects logistic
regression. We compared entry of the family member with
dementia to 24 hour care between groups using a simple
comparison of proportions (not allowing for clustering) because
of small numbers.
All statistical analyses followed a predefined analysis plan and
were carried out using STATA version 11.
Results
The figure⇓ shows the recruitment and flow of participants in
the trial. Of the 450 carers eligible for the study, 260 (58%)
consented to take part in the trial; the remained refused to
participate or were not contactable. The numbers recruited from
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individual trusts were: Camden and Islington Foundation Trust
n=183, North East London Foundation Trust n=16, Dementia
Research Centre n=35, and North Essex Partnership Foundation
Trust n=26. Table 1⇓ compares the known personal details of
those who consented and those who did not and shows that the
study sample had good external validity. Those who consented
were, however, slightly more likely to be married or partnered
with the recipient of care than those who did not consent.
Overall, 173 (67%) participants were randomised to the
intervention group and 87 to treatment as usual. In general, the
randomised groups were well balanced for patient and baseline
carer personal and clinical characteristics (tables 2⇓ and 3⇓).
Employment status, however, appeared imbalanced, with a
higher proportion of retired carers in the intervention group.
Carers in the intervention group were also slightly older and
included a higher proportion of those currently unmarried.
Higher proportions of carers in the intervention group were
living with the recipient of care, were spouses or partners, and
with either no school level qualifications or tertiary education.
In terms of clinical characteristics those in the intervention group
less frequently had case level anxiety and had slightly lower
anxiety scores and total scores on the hospital anxiety and
depression scale.
The 10 therapists (seven women) in the intervention arm each
saw between 11 and 32 participants. All the therapists were
psychology graduates with no further clinical training and aged
20-35 years.
Treatment fidelity and participant follow-up
Over the eight months after baseline, 10 carers from the control
group and 21 from the intervention group were withdrawn or
lost to follow-up (figure). These included two who died (one
from each group). In the intervention group one carer gave
inconsistent data and was withdrawn by the team, and one was
in prison. The participants gave several reasons for withdrawal:
wanted treatment but not allocated to it (four, treatment as
usual), did not feel the intervention was for them (three,
intervention), too busy (four, intervention; one, treatment as
usual), disliked talking about the recipient of care without him
or her present (one, treatment as usual; one, intervention), other
family member wanted them to withdraw (one, treatment as
usual), unwell (one, intervention), recipient of care died (one,
treatment as usual), and trial too upsetting (one, intervention).
Six gave no reason (five, intervention; one, treatment as usual).
Three others did not participate and were not contactable at the
four or eight month follow-up, but have since come back to the
study.
Overall, 128 participants in the intervention group agreed to a
therapy session being audio-recorded to assess fidelity to the
manual (from 1 for poor to 5 for excellent); 100 (78%) rated
fidelity as 5, 20 (16%) as 4, five as 3, and three as 2.
Of the eight therapy sessions offered, five or more were attended
by 130 (75%) carers in the intervention group (table 4⇓). Eight
(5%) of those in the intervention group withdrew before taking
part in any therapy sessions. Adherence (attending ≥5 sessions)
was better in those of white ethnicity compared with other
ethnicity (n=110 (78%) v n=19 (61%)) and slightly better for
male compared with female carers (46 (81%) v 84 (72%)) and
those with at least A level education (56 (80%) v 74 (72%)).
Adherence was similar by age group (<60, 75 (77%) v 55 (73%))
and employment status (in paid work 49 (78%) v other 81
(74%)).
Primary and secondary clinical outcome
results
Table 5⇓ summarises average scores at months 4 and 8, and
gives the estimated effect of therapy versus treatment as usual
for primary and secondary outcomes.
Analysis of the total score on the hospital anxiety and depression
scale, adjusting for centre and baseline score and for factors
related to outcome (carers’ age and sex, neuropsychiatric
inventory score, and Zarit burden interview score) showed a
mean difference of −1.80 points (95% confidence interval −3.29
to −0.31 points; P=0.02) in favour of the intervention. If the
model did not include factors relating to outcome then the results
were similar, with an average decrease in score of −1.46 (−2.89
to −0.03); P=0.05). The therapist intracluster correlation at four
months was 0.02 (95% confidence interval 0.00 to 0.09) and at
eight months was 0.00 (0.00 to 0.08). Sensitivity analyses
adjusting for significant personal and clinical predictors of
missing values—namely, recipient of care living with carer,
relationship to carer, carer having dependent children at home,
ethnicity of recipient of care, and COPE dysfunction
score—gave similar results (mean difference −1.53, 95%
confidence interval −2.96 to −0.10) as did analyses adjusting
for baseline imbalances—namely, carer’s work situation,
relationship to carer and recipient of care, and carer’s education
and living situation (mean difference −1.78, −3.30 to −0.27).
Models including an interaction with time showed no evidence
of a differential effect of the intervention between the four and
eight month time points (P=0.90). Models for the individual
anxiety and depression continuous scales also showed evidence
of beneficial effects of the intervention (table 5).
Secondary outcomes
Depression and anxiety caseness—a reduction in the odds of
cases of depression on the hospital anxiety and depression scale
in the intervention group compared with treatment as usual was
significant, with an odds four times higher for the treatment as
usual group (odds ratio 0.24, 95% confidence interval 0.07 to
0.76). Similarly there was some evidence for a reduction in odds
of caseness on the hospital anxiety and depression scale (0.30,
0.08 to 1.05).
Significant abuse—there was some evidence of a decrease in
abusive behaviour on the modified conflict tactics scale (odds
ratio 0.48, 0.18 to 1.27).
Quality of life of carer and recipient of care—There was no
significant difference between the groups for overall quality of
life for the family members with dementia. The health status
questionnaire, mental health scale for the carer did, however,
indicate significantly higher average scores and hence improved
mental health (mean difference 4.09, 95% confidence interval
0.34 to 7.83).
Entry of family members with dementia to 24
hour care
Fourteen family members with dementia were admitted to a
care home during the eight month follow-up period; three (4%)
in the treatment as usual group and 11 (6%) in the intervention
group. Simple analyses indicate no evidence of a statistically
significant difference between the groups (Fishers exact test
P=0.56). This outcome will be considered more extensively in
analyses of longer term follow-up. Cost effective results are
reported in the accompanying paper.
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Discussion
Carers of family members with dementia referred to secondary
or tertiary care benefit from a structured psychological
intervention delivered by psychology graduates, supervised by
clinical psychologists. The effect size in terms of the total mean
affective symptoms was small, but previous evidence where
researchers set out to calculate what a clinically important
difference would be on the hospital anxiety and depression scale,
suggests that treatment effects are in the range that is important
to patients.35 Incidence of clinical depression increased in the
treatment as usual group but not in the intervention group and
the odds ratios indicate that at follow-up, those in the treatment
as usual group were four times more likely to have clinically
significant depression, suggesting the intervention is clinically
important. In keeping with this, the quality of life improved for
carers. We thought that in the long term this intervention may
also delay admission to care homes for people with dementia
and therefore increase their quality of life. This short term
follow-up over eight months did not show that but we plan to
continue collecting data at two years and for care home
admission over the following five years, and we will reconsider
this effect.
Strengths and limitations of this study
This was a pragmatic study with broad inclusion criteria,
including participants from a range of settings and backgrounds,
with varied personal characteristics, suggesting the results are
generalisable and directly relevant to the National Health
Service. Further evidence of external validity is the similarity
in characteristics between those who did and did not consent.
The intervention is standardised, and the high fidelity ratings
and the low intracluster correlations within therapists suggested
that the intervention can be delivered consistently. The follow-up
rate of 88.1% overall was satisfactory, with similar rates in both
arms. The instruments were validated and standardised.
The levels of anxiety and depressive symptoms, case level
anxiety and depression, neuropsychiatric symptoms, and carer
abusive behaviour were slightly higher than in a recent cohort
study of newly referred people with dementia, so those with
more problems may have been more likely to consent to the
study.6 36 We informed the clinical teams about abusive
behaviour of the carers in the treatment as usual group when
there was not an intervention in place and thus may have
improved the outcome for that group. Although randomisation
was independent and follow-up raters were blinded to allocation,
the carers inevitably knew to which group they had been
randomised.We found it difficult to deliver the therapy to people
who did not speak English, although only four such carers were
in the study, three of whom were in the intervention group. In
retrospect, we did not allow enough time and budget to translate
the whole manual and deliver the therapy with translators. As
translating the manual is a one-off process, this will be less of
a problem as we come to implement our findings in the NHS.
Comparisonswith other studies andmeaning
and implications of this study
Other recent psychosocial interventions have been, in contrast,
ineffective for both carer psychological symptoms and quality
of life; thus showing our findings were not explained by the
offer of a therapist to spend time and attention.9 37 Our study is
consistent with the US study from which we derived the
intervention, in that a similar intervention helped depressive
symptoms in carers, but it was more practical for many carers
as we did not require them all to come to a group session at the
same time. It was deliverable by psychology graduates without
previous clinical training—a group who are relatively
inexpensive and available. Within the United States, a similar
therapy to ours delivered at an individual level was found to be
significantly cost effective in completers compared with controls
for freeing up time spent on care.38 We are not aware of any
other interventions in this group for which health economic
evaluations have been undertaken and this is in our
accompanying paper. In our earlier studies we found that family
carers tended to become more anxious and depressed over time
without intervention, and that this was associated with an
increase in abusive behaviour, and thus we included carers who
were not depressed at presentation to services.39 40The preventive
effect that was found highlights that these carers can benefit
from early intervention.
The intervention was effective in the short term and acceptable
to most participants, who made time for it despite their care
commitments, and often also being employed or unwell
themselves. We found little evidence of harm with withdrawal
from the treatment, being at a similar rate to withdrawal from
the treatment as usual arm, although one carer said they found
the therapy too upsetting and three thought it was not for them.
We think memory services should consider offering the
intervention as part of the routine management of dementia, and
it is being piloted by our local services. Our group has developed
the training and the manual is available (see supplementary file).
Currently, no interventions have been shown to reduce the abuse
of elders.41 Our study was not powered to find a significant
change in abuse, and for ethical reasons we made clinicians
aware of abuse in the control group; thus carers were often
offered clinical and social support.
Unanswered questions and future research
This study reports short term outcomes for carers and that there
was no evidence of a difference between groups at four and
eight months, thus possibly suggesting some lasting effect. In
one study, continued therapy led to improvement in carers’
mental health over years and a reduction in nursing home
admissions for patients, but we do not yet know whether our
short therapeutic intervention to change strategies will also be
effective in the longer term.42
We are following this cohort to answer these questions. In
addition, the effect on abuse is promising but more work is
required for confirmation of this effect. The longer term outcome
may help to clarify this situation.
Conclusions
The intervention was clinically effective for the impact on carers
in the short term. Further follow-up will consider longer term
effects on carers’ mood, quality of life, and abusive behaviour,
and on cost effectiveness, and whether, as in other longer term
studies, patients’ time to care home admission has been
lengthened.43
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What is already known on this topic
About 40% of carers of family members with dementia have clinically significant depression or anxiety, and others have significant
psychological symptoms
A manual based group intervention delivered by clinical psychologists in the United States has been shown to reduce depression
Effective therapies have so far only been delivered by highly trained clinical psychologists
What this study adds
A manual based coping strategy programme can be delivered by graduate psychologists without clinical training
The intervention was effective in reducing affective symptoms and case level depression of carers of family members with dementia
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Tables
Table 1| External validity of eligible carers who consented to the trial compared with those who were not randomised
No (%) of eligible carers
Characteristics Randomised (n=260)Not randomised (n=190)
82 (32)56 (29)Male carers
108 (42)75 (39)Male recipients of care
Carers relationship to recipient of care:
109 (42)65 (34)Spouse or partner
113 (44)90 (47)Child
6 (2)8 (4)Friend
12 (5)4 (2)Daughter’s or son’s partner
8 (3)8 (4)Nephew or niece
6 (2)4 (2)Grandchild
4 (2)5 (3)Sibling
2 (1)6 (3)Other
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Table 2| Baseline personal characteristics of carers and family members with dementia by randomisation group. Values are numbers
(percentages) unless stated otherwise
Recipients of careCarers
Characteristics Intervention group (n=173)
Treatment as usual group
(n=87)Intervention group (n=173)
Treatment as usual group
(n=87)
79.9 (8.3) (55-95)78.0 (9.9) (53-96)62.0 (14.6) (18-88)56.1 (12.3) (27-89)Mean (SD) age (years) (range)
102 (59)50 (57)116 (67)62 (71)Women
71 (41)37 (43)57 (33)25 (29)Men
n=172Ethnicity:
126 (73)61 (70)131 (76)65 (75)White UK
14 (8)6 (7)10 (6)5 (6)White other
33 (19)20 (23)31 (18)17 (20)Black and in minority ethnic group
Marital status:
92 (53)47 (54)61 (35)25 (29)Not currently married
81 (47)40 (46)112 (65)62 (71)Married or cohabiting
Education:
73 (45)44 (51)45 (26)18 (21)No qualifications
28 (17)16 (19)51 (29)33 (38)School level qualifications
63 (38)26 (30)77 (45)36 (41)Further education
Employment status:
NANA36 (21)28 (32)Full time
NANA27 (16)20 (23)Part time
NANA80 (46)23 (26)Retired
NANA30 (17)16 (18)Not working
113 (65)50 (57)NANALiving with carer
Relationship to recipient of care:
NANA78 (45)31 (36)Spouse or partner
NANA71 (41)42 (48)Child
NANA24 (14)14 (16)Other
NA=not applicable.
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Table 3 Baseline clinical characteristics of carers and family members with dementia by randomisation group. Values are means (standard
deviations) unless stated otherwise
Recipients of careCarers
Characteristics Intervention groupTreatment as usual groupIntervention group (n=172)
Treatment as usual group
(n=87)
HADS scale:
NANA13.5 (7.3)14.8 (7.4)Total score
NANA8.1 (4.4)9.3 (4.3)Anxiety
NANA5.4 (3.8)5.5 (3.9)Depression
30.2 (6.9) (n=170)29.9 (6.9) (n=87)NANAQuality of life-Alzheimer’s disease
NANA58.3 (22.4) (n=171)58.2 (21.7)Health status questionnaire (mental health)
Total scores:
NANA2.5 (2.9)2.7 (3.1)MCTS scale
NANA35.3 (18.4) (n=165)38.1 (17.0) (n=84)Zarit burden interview
24.0 (19.0) (n=171)26.6 (20.1) (n=86)NANANeuropsychiatric inventory
1.2 (0.6) (n=171)1.3 (0.6) (n=87)NANAClinical dementia scale
NANA85 (49)48 (55)HADS anxiety case (No (%) scoring ≥9)
NANA36 (21)17 (20)HADS depression case (No (%) scoring
≥9)
NANA82 (48)38 (44)MCTS (No (%) with at least 1 item scoring
≥2)
HADS=hospital anxiety and depression scale; MCTS=modified conflict tactics scale; NPI=neuropsychiatric inventory.
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Table 4| Number of sessions attended by carers randomised to intervention group
No (%) of carersNo of sessions attended
8 (5)None
9 (5)1
11(6)2
8 (5)3
7 (4)4
3 (2)5
1 (1)6
1 (1)7
125 (72)8
173 (100)Total
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;347:f6276 doi: 10.1136/bmj.f6276 (Published 25 October 2013) Page 12 of 14
RESEARCH
Table 5| Primary and secondary outcomes at follow-up for carers in intervention and treatment as usual groups. Values are means (standard
deviations) unless otherwise stated
Treatment effect (95% CI), P valueIntervention groupTreatment as usual group
Outcomes Adjusted†Adjusted*8 months4 months8 months4 months
−1.80 (−3.29 to
−0.31), 0.02 (n=220)
−1.46 (−2.89 to
−0.03), 0.05 (n=229)
12.9 (7.9) (n=133)12.4 (7.4) (n=150)14.9 (8.0) (n=71)14.3 (7.4) (n=75)HADS total score
0.59 (−0.72 to 1.89)
(n=197)
0.80 (–0.45 to 2.05)
(n=205)
30.3 (7.3) (n=120)30.7 (6.5) (n=137)29.7 (6.3) (n=61)29.8 (5.8) (n=66)Quality of
life-Alzheimer’s
disease
4.09 (0.34 to 7.83)
(n=211)
4.55 (0.92 to 8.17)
(n=219)
58.6 (22.0)
(n=122)
62.7 (20.8)
(n=144)
58.2 (19.2) (n=66)58.4 (18.0) (n=72)Health status
questionnaire
(mental health)
HADS:
–0.91 (–1.76 to–0.07)
(n=220)
–0.62 (–1.43 to 0.19)
(n=229)
7.6 (4.4) (n=133)7.5 (4.2) (n=150)8.8 (4.4) (n=71)8.6 (4.2) (n=75)Anxiety
–0.91 (–1.71 to–0.10)
(n=220)
–0.88(–1.68 to–0.09)
(n=229)
5.2 (4.0) (n=133)4.9 (3.9) (n=150)6.1 (4.2) (n=71)5.7 (4.0) (n=75)Depression
0.30‡ (0.08 to 1.05)
(n=220)
0.35‡ (0.11 to 1.18)
(n=229)
53 (40) (n=133)54 (36) (n=150)33 (46) (n=71)36 (48) (n=75)Anxiety case (No
(%) scoring ≥9)
0.24‡ (0.07 to 0.76)
(n=220)
0.25‡ (0.08 to 0.81)
(n=229)
28 (21) (n=133)25 (17) (n=150)23 (32) (n=71)18 (24) (n=75)Depression case
(No (%) scoring ≥9)
0.48‡ (0.18 to 1.27)
(n=206)
0.47‡ (0.18 to 1.23)
(n=214)
40 (33) (n=120)50 (36) (n=139)23 (36) (n=64)28 (41) (n=69)MCTS (No (%) with
at least 1 item
scoring ≥2)
Treatment effect estimates (differences and odds ratios) are from models taking into account repeated measurements and therapist clustering in intervention arm
and that are adjusted for baseline characteristics.
HADS=hospital anxiety and depression scale, MCTS=modified conflict tactics scale.
*Adjusted for baseline score and centre.
†Adjusted also for carers’ age, sex, neuropsychiatric inventory score, and Zarit burden interview.
‡Odds ratio.
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Figure
Flow of participants through study
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